InsiderClue
Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

Idexx Laboratories

IDXX Clue Score66
United States Fiscal year ends December CIK 0000874716
$518.00 +0.95% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $518.00 −15.47% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue1,775.4Operating income350.2Net income222.0EPS, diluted2.44Fiscal year 2017Revenue1,969.1 +10.9%Operating income413.0Net income263.1 +18.5%EPS, diluted2.94 +20.5%Fiscal year 2018Revenue2,213.2 +12.4%Operating income491.3Net income377.0 +43.3%EPS, diluted4.26 +44.9%Fiscal year 2019Revenue2,406.9 +8.8%Operating income552.8Net income427.7 +13.4%EPS, diluted4.89 +14.8%Fiscal year 2020Revenue2,706.7 +12.5%Operating income694.5Net income581.8 +36.0%EPS, diluted6.71 +37.2%Fiscal year 2021Revenue3,215.4 +18.8%Operating income932.0Net income744.8 +28.0%EPS, diluted8.60 +28.2%Fiscal year 2022Revenue3,367.3 +4.7%Operating income898.8Net income679.1 −8.8%EPS, diluted8.03 −6.6%Fiscal year 2023Revenue3,661.0 +8.7%Operating income1,097.1Net income845.0 +24.4%EPS, diluted10.06 +25.3%Fiscal year 2024Revenue3,897.5 +6.5%Operating income1,128.3Net income887.9 +5.1%EPS, diluted10.67 +6.1%Fiscal year 2025Revenue4,303.7 +10.4%Operating income1,360.0Net income1,059.5 +19.3%EPS, diluted13.08 +22.6%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 1,775.4 1,969.1 2,213.2 2,406.9 2,706.7 3,215.4 3,367.3 3,661.0 3,897.5 4,303.7
Growth +10.9% +12.4% +8.8% +12.5% +18.8% +4.7% +8.7% +6.5% +10.4%
Operating income 350.2 413.0 491.3 552.8 694.5 932.0 898.8 1,097.1 1,128.3 1,360.0
Net income 222.0 263.1 377.0 427.7 581.8 744.8 679.1 845.0 887.9 1,059.5
Growth +18.5% +43.3% +13.4% +36.0% +28.0% −8.8% +24.4% +5.1% +19.3%
EPS, diluted 2.44 2.94 4.26 4.89 6.71 8.60 8.03 10.06 10.67 13.08
Growth +20.5% +44.9% +14.8% +37.2% +28.2% −6.6% +25.3% +6.1% +22.6%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin54.9%Operating margin19.7%Net margin12.5%Free cash flow margin15.4%Fiscal year 2017Gross margin55.7%Operating margin21.0%Net margin13.4%Free cash flow margin15.2%Fiscal year 2018Gross margin56.1%Operating margin22.2%Net margin17.0%Free cash flow margin12.8%Fiscal year 2019Gross margin56.7%Operating margin23.0%Net margin17.8%Free cash flow margin12.6%Fiscal year 2020Gross margin58.0%Operating margin25.7%Net margin21.5%Free cash flow margin20.0%Fiscal year 2021Gross margin58.8%Operating margin29.0%Net margin23.2%Free cash flow margin19.8%Fiscal year 2022Gross margin59.5%Operating margin26.7%Net margin20.2%Free cash flow margin11.7%Fiscal year 2023Gross margin59.8%Operating margin30.0%Net margin23.1%Free cash flow margin21.1%Fiscal year 2024Gross margin61.0%Operating margin29.0%Net margin22.8%Free cash flow margin20.7%Fiscal year 2025Gross margin61.8%Operating margin31.6%Net margin24.6%Free cash flow margin24.6%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 54.9% 55.7% 56.1% 56.7% 58.0% 58.8% 59.5% 59.8% 61.0% 61.8%
Operating margin 19.7% 21.0% 22.2% 23.0% 25.7% 29.0% 26.7% 30.0% 29.0% 31.6%
Net margin 12.5% 13.4% 17.0% 17.8% 21.5% 23.2% 20.2% 23.1% 22.8% 24.6%
Free cash flow margin 15.4% 15.2% 12.8% 12.6% 20.0% 19.8% 11.7% 21.1% 20.7% 24.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow338.9Capital expenditure−64.8Free cash flow274.2Buybacks−304.1Fiscal year 2017Operating cash flow373.3Capital expenditure−74.4Free cash flow298.9 +9.0%Buybacks−282.6Fiscal year 2018Operating cash flow400.1Capital expenditure−115.8Free cash flow284.3 −4.9%Buybacks−369.3Fiscal year 2019Operating cash flow459.2Capital expenditure−155.0Free cash flow304.2 +7.0%Buybacks−301.7Fiscal year 2020Operating cash flow648.1Capital expenditure−107.0Free cash flow541.1 +77.9%Buybacks−182.8Fiscal year 2021Operating cash flow755.5Capital expenditure−119.5Free cash flow636.0 +17.5%Buybacks−746.8Fiscal year 2022Operating cash flow543.0Capital expenditure−148.8Free cash flow394.1 −38.0%Buybacks−819.7Fiscal year 2023Operating cash flow906.5Capital expenditure−133.6Free cash flow772.9 +96.1%Buybacks−71.9Fiscal year 2024Operating cash flow929.0Capital expenditure−120.9Free cash flow808.1 +4.6%Buybacks−837.0Fiscal year 2025Operating cash flow1,181.8Capital expenditure−124.7Free cash flow1,057.1 +30.8%Buybacks−1,217.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 338.9 373.3 400.1 459.2 648.1 755.5 543.0 906.5 929.0 1,181.8
Capital expenditure −64.8 −74.4 −115.8 −155.0 −107.0 −119.5 −148.8 −133.6 −120.9 −124.7
Free cash flow 274.2 298.9 284.3 304.2 541.1 636.0 394.1 772.9 808.1 1,057.1
Growth +9.0% −4.9% +7.0% +77.9% +17.5% −38.0% +96.1% +4.6% +30.8%
Buybacks −304.1 −282.6 −369.3 −301.7 −182.8 −746.8 −819.7 −71.9 −837.0 −1,217.0

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash154.9Total debt593.7Net cash (debt)−438.8Shareholders’ equity−108.4Fiscal year 2017Cash187.7Total debt606.6Net cash (debt)−418.9Shareholders’ equity−54.1Fiscal year 2018Cash123.8Total debt601.8Net cash (debt)−478.0Shareholders’ equity−9.5Fiscal year 2019Cash90.3Total debt698.9Net cash (debt)−608.6Shareholders’ equity177.5Debt to equity3.94Fiscal year 2020Cash383.9Total debt908.5Net cash (debt)−524.6Shareholders’ equity632.1Debt to equity1.44Fiscal year 2021Cash144.5Total debt850.2Net cash (debt)−705.7Shareholders’ equity690.0Debt to equity1.23Fiscal year 2022Cash112.5Total debt769.4Net cash (debt)−656.8Shareholders’ equity608.7Debt to equity1.26Fiscal year 2023Cash453.9Total debt697.9Net cash (debt)−243.9Shareholders’ equity1,484.5Debt to equity0.47Fiscal year 2024Cash288.3Total debt617.6Net cash (debt)−329.3Shareholders’ equity1,595.3Debt to equity0.39Fiscal year 2025Cash180.1Total debt449.8Net cash (debt)−269.8Shareholders’ equity1,605.4Debt to equity0.28
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 154.9 187.7 123.8 90.3 383.9 144.5 112.5 453.9 288.3 180.1
Total debt 593.7 606.6 601.8 698.9 908.5 850.2 769.4 697.9 617.6 449.8
Net cash (debt) −438.8 −418.9 −478.0 −608.6 −524.6 −705.7 −656.8 −243.9 −329.3 −269.8
Shareholders’ equity −108.4 −54.1 −9.5 177.5 632.1 690.0 608.7 1,484.5 1,595.3 1,605.4
Debt to equity n/a n/a n/a 3.94 1.44 1.23 1.26 0.47 0.39 0.28

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
1,775.4 1,969.1 2,213.2 2,406.9 2,706.7 3,215.4 3,367.3 3,661.0 3,897.5 4,303.7
Growth +10.9% +12.4% +8.8% +12.5% +18.8% +4.7% +8.7% +6.5% +10.4%
800.0 871.7 971.7 1,041.4 1,135.6 1,325.9 1,363.0 1,471.0 1,518.6 1,644.1
975.4 1,097.4 1,241.5 1,365.5 1,571.0 1,889.4 2,004.3 2,190.0 2,378.9 2,659.6
Growth +12.5% +13.1% +10.0% +15.0% +20.3% +6.1% +9.3% +8.6% +11.8%
101.1 109.2 117.9 133.2 141.2 161.0 254.8 191.0 219.8 251.2
207.0 220.9 244.9 261.3 300.8 309.7 326.2 335.8 442.3 404.8
350.2 413.0 491.3 552.8 694.5 932.0 898.8 1,097.1 1,128.3 1,360.0
Growth +17.9% +19.0% +12.5% +25.6% +34.2% −3.6% +22.1% +2.8% +20.5%
321.8 381.1 457.7 522.2 662.0 902.7 860.0 1,061.2 1,109.8 1,324.2
99.8 117.8 80.7 94.4 79.9 157.8 180.9 216.1 222.0 264.7
222.0 263.1 377.0 427.7 581.8 744.8 679.1 845.0 887.9 1,059.5
Growth +18.5% +43.3% +13.4% +36.0% +28.0% −8.8% +24.4% +5.1% +19.3%
Per share
2.47 3.00 4.34 4.97 6.82 8.74 8.12 10.17 10.77 13.17
2.44 2.94 4.26 4.89 6.71 8.60 8.03 10.06 10.67 13.08
Growth +20.5% +44.9% +14.8% +37.2% +28.2% −6.6% +25.3% +6.1% +22.6%
89.7 87.8 86.9 86.1 85.3 85.2 83.6 83.1 82.5 80.4
90.9 89.6 88.5 87.5 86.7 86.6 84.6 84.0 83.2 81.0
Growth −1.4% −1.2% −1.0% −0.9% −0.2% −2.3% −0.7% −0.9% −2.7%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 9.7% a year over five years, and earnings per share grew 14.3% a year.
  • The diluted share count fell 6.6% in five years, so buybacks did some of the work per share.
  • Operating margin is up 5.9 points on five years ago, at 31.6%.
  • Profitable in every one of the 10 years on file.